Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2014.10.30
第三届董事会第四次会议决议公告
2014.10.30
第三届监事会第四次会议决议公告
2014.10.30
关于增加自有资金购买银行保本理财产品额度的公告
2014.10.30
关于开展利率掉期和远期外汇交易的公告
2014.10.30
关于公司向花旗银行（中国）深圳分行申请授信的公告
2014.10.30
关于召开2014年第四次临时股东大会的通知
2014.10.11
关于全资子公司完成增资变更注册的公告
2014.09.26
关于全资子公司完成工商注销手续的公告
2014.09.24
关于公司使用自有资金购买低风险理财产品的进展公告
2014.09.24
2014年第三次临时股东大会决议公告
第一页
上一页
109
110
111
112
113
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
